Bruno Melillo retweeted
Targeting extrachromosomal DNA in human cancers
nature.com/articles/s41573-0…
rdcu.be/e2kVS
This new Review discusses ecDNA biology, challenges faced by current therapeutic and detection approaches and discoveries that highlight emerging therapeutic vulnerabilities
Bruno Melillo retweeted
Excited to share this work profiling a new P(V)-electrophile using our stereoprobe platform, where we discover a first-in-class, cell-active inhibitor of integral membrane protein TLCD1 and ID critical catalytic residues! Great collab w/@BaranLabReads biorxiv.org/content/10.1101/…
Bruno Melillo retweeted
#Technology Chemical tools to expand the ligandable proteome: Diversity-oriented synthesis-based photoreactive stereoprobes by @d_ogasa, @brumelillo, @bencravatt at @scrippsresearch @broadinstitute @harvardmed @MassGeneralNews dlvr.it/TGwBK2
Bruno Melillo retweeted
Online now! Chemical tools to expand the ligandable proteome: Diversity-oriented synthesis-based photoreactive stereoprobes by @d_ogasa, @brumelillo, @bencravatt, et al at @scrippsresearch @broadinstitute @harvardmed dlvr.it/TGFYHz
Bruno Melillo retweeted
Today #CancerGrandChallenges team eDyNAmiC and their international collaborators published 3️⃣ papers in
@Nature 📣
They show the prevalence of ecDNA in cancer, identify fundamental mechanisms and an actionable target now being tested in the clinic.
More: bit.ly/4dUMU00
Bruno Melillo retweeted
For years, scientists have considered transcription factors to be undruggable, but new research published this month in Molecular Cell shows they may be druggable after all. cen.acs.org/biological-chemi… .
Bruno Melillo retweeted
New findings in @MolecularCell by Ben Cravatt and @Michael_A_Erb identify a ligandable site on the “undruggable” FOXA1 transcription factor in hormone-driven cancers. Dual ABPP maps FOXA1-small molecule interactions, guiding therapeutic design. More at: ow.ly/cB2M50TM2gb
Bruno Melillo retweeted
We keep stumbling on molecular glues, but how can they be made for a pre-selected target? We’ve been working on this question, envisioning a high-throughput chemistry (HTC)-based approach to convert pre-existing ligands into molecular glues. biorxiv.org/content/10.1101/…
Bruno Melillo retweeted
Simple, Enantiocontrolled Azetidine Library Synthesis via Strain Release Functionalization of 1-Azabicyclobutanes. A fantastic collaboration with the Cravatt lab.
A simple, modular, programmable approach to access complex stereopure azetidines through strain-release functionalization is disclosed. The synthetic methods developed enable parallel synthesis of stereodefined azetidines that would be otherwise laborious to produce. Given the privileged nature of these structures, a set of stereoprobes for use in activity-based protein profiling was prepared and evaluated, revealing proteins in human cancer cells with were liganded with clear stereo- and chemoselectivity.
Appearing today in @ChemRxiv : chemrxiv.org/engage/chemrxiv…
Bruno Melillo retweeted
Ben Cravatt and @YuanjinZhang1 report a paralog-hopping approach leveraging chemical proteomic data on covalently liganded cysteines, revealing an allosteric pocket shared by cysteine-containing CCNE2 and cysteine-less paralogous proteins. Read it here rdcu.be/dUlxn
Bruno Melillo retweeted
The Cravatt Lab, with @brumelillo and @EvertNjomen, identified novel proteins that could be targeted to delay or even prevent #cancer cell division. Published in @NatureChemistry, this study paves the way for developing innovative cancer therapies. More: ow.ly/jaWL50TeCWB
Bruno Melillo retweeted
Excited to share a key part of my postdoctoral work in the Cravatt lab at @ScrippsResearch, published today in @NatureChemistry! Huge thanks to collaborators @brumelillo, @_RachelHayward, @VividionRx, and all coauthors.
Bruno Melillo retweeted
Prof. Keary Engle of the @EngleLab is the new Dean of Graduate and Postdoctoral Studies at Scripps Research, leading the @ScrippsGradPrgm. An alumnus, Engle brings personal experience and is committed to mentoring future researchers. More: ow.ly/FcHR50Su8l2
Bruno Melillo retweeted
Introducing CHARM: a new epigenome editor to methylate DNA at the promoter of a targeted gene.
Our lab's collaboration with @JswLab's @EdwinNNeumann & @TessaBertozzi shows deep silencing of brain PrP
Paper: science.org/doi/10.1126/scie…
Blog: cureffi.org/2024/06/27/intro…
Bruno Melillo retweeted
Beautiful talk by Benjamin Cravatt at #AACR24 about ABPP & targeting cysteines to extend druggable space. Featuring the recently disclosed FOXA1 stereospecific covalent ligand derived from marrying diversity-oriented chemistry @SchreiberStuart with the power of chemoproteomics.
Bruno Melillo retweeted
Excited to share my postdoctoral work in the Cravatt lab. We described a set of stereo- and regiochemically defined spirocycle acrylamides and their chemical proteomic analysis in human cancer cells, leading to the discovery of ERCC3 degraders and other novel ligands.
Bruno Melillo retweeted
Redirecting the pioneering function of FOXA1 with covalent small molecules biorxiv.org/cgi/content/shor… #bioRxiv
Bruno Melillo retweeted
Together with the Cravatt group, we have a new manuscript out reporting the chemoproteomic discovery of covalent FOXA1 ligands that bind its DNA-binding domain, corrupt its motif preferences, and redistribute it on the genome. 1/11 biorxiv.org/content/10.1101/…
Redirecting the pioneering function of FOXA1 with covalent small molecules biorxiv.org/cgi/content/shor… #bioRxiv
Bruno Melillo retweeted
Excited to share my postdoc work in Cravatt lab & Schreiber lab!
We described photo-stereoprobes, DOS-inspired photo-reactive probes, for expanding the ligandable proteome. 🧵
doi.org/10.1101/2024.02.27.5…
Bruno Melillo retweeted
I am delighted to share that the main body of my postdoctoral work with #BenCravatt in collaboration with @brumelillo, #RamnikXavier and @SchreiberStuart is finally out which harnessed photoreactive stereoprobes to expand the ligandable proteome: tinyurl.com/f3uxbjj3.


































